AAAAAA

   
Results: 1-10 |
Results: 10
EFFECTS OF L-HISTIDINOL ON THE ANTITUMOR-ACTIVITY AND ACUTE CARDIOTOXICITY OF DOXORUBICIN IN MICE
Authors: ALSHABANAH OA BADARY OA ALGHARABLY NM ALSAWAF HA
Citation: Oa. Alshabanah et al., EFFECTS OF L-HISTIDINOL ON THE ANTITUMOR-ACTIVITY AND ACUTE CARDIOTOXICITY OF DOXORUBICIN IN MICE, Pharmacological research, 38(3), 1998, pp. 225-230
EFFECT OF CREMOPHOR-EL ON THE PHARMACOKINETICS, ANTITUMOR-ACTIVITY AND TOXICITY OF DOXORUBICIN IN MICE
Authors: BADARY OA ALSHABANAH OA ALGHARABLY NM ELMAZAR MMA
Citation: Oa. Badary et al., EFFECT OF CREMOPHOR-EL ON THE PHARMACOKINETICS, ANTITUMOR-ACTIVITY AND TOXICITY OF DOXORUBICIN IN MICE, Anti-cancer drugs, 9(9), 1998, pp. 809-815
PHARMACOKINETICS AND ACUTE CARDIOTOXICITY OF DOXORUBICIN AFTER INTRAVENOUS ADMINISTRATION TO RATS WITH STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS
Authors: ALSHABANAH OA BADARY OA ELKASHEF HA ALBEKAIRI AM ELMAZAR MMA
Citation: Oa. Alshabanah et al., PHARMACOKINETICS AND ACUTE CARDIOTOXICITY OF DOXORUBICIN AFTER INTRAVENOUS ADMINISTRATION TO RATS WITH STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS, The FASEB journal, 12(4), 1998, pp. 2384-2384
THYMOQUINONE PROTECTS AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY WITHOUT COMPROMISING ITS ANTITUMOR-ACTIVITY
Authors: ALSHABANAH OA BADARY OA NAGI MN ALGHARABLY NM ALRIKABI AC ALBEKAIRI AM
Citation: Oa. Alshabanah et al., THYMOQUINONE PROTECTS AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY WITHOUT COMPROMISING ITS ANTITUMOR-ACTIVITY, Journal of experimental & clinical cancer research, 17(2), 1998, pp. 193-198
ACUTE AND SUBCHRONIC TOXICITY OF THYMOQUINONE IN MICE
Authors: BADARY OA ALSHABANAH OA NAGI MN ALBEKAIRI AM ELMAZAR MMA
Citation: Oa. Badary et al., ACUTE AND SUBCHRONIC TOXICITY OF THYMOQUINONE IN MICE, Drug development research, 44(2-3), 1998, pp. 56-61
EFFECT OF L-HISTIDINOL ON CISPLATIN NEPHROTOXICITY IN THE RAT
Authors: BADARY OA NAGI MN ALSAWAF HA ALHARBI M ALBEKAIRI AM
Citation: Oa. Badary et al., EFFECT OF L-HISTIDINOL ON CISPLATIN NEPHROTOXICITY IN THE RAT, Nephron, 77(4), 1997, pp. 435-439
THYMOQUINONE AMELIORATES THE NEPHROTOXICITY INDUCED BY CISPLATIN IN RODENTS AND POTENTIATES ITS ANTITUMOR-ACTIVITY
Authors: BADARY OA NAGI MN ALSHABANAH OA ALSAWAF HA ALSOHAIBANI MO ALBEKAIRI AM
Citation: Oa. Badary et al., THYMOQUINONE AMELIORATES THE NEPHROTOXICITY INDUCED BY CISPLATIN IN RODENTS AND POTENTIATES ITS ANTITUMOR-ACTIVITY, Canadian journal of physiology and pharmacology, 75(12), 1997, pp. 1356-1361
ALTERED UTERINE SENSITIVITY TO OXYTOCIN AND PROSTAGLANDIN-F2-ALPHA INDIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED RAT MAMMARY-CARCINOMA - THE EFFECTS OF TAMOXIFEN AND OR RECOMBINANT HUMAN INTERFERON-ALPHA-2B THERAPY/
Authors: BADARY OA AGHA AM ELSAYED ESM HAMADA FMA
Citation: Oa. Badary et al., ALTERED UTERINE SENSITIVITY TO OXYTOCIN AND PROSTAGLANDIN-F2-ALPHA INDIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED RAT MAMMARY-CARCINOMA - THE EFFECTS OF TAMOXIFEN AND OR RECOMBINANT HUMAN INTERFERON-ALPHA-2B THERAPY/, Pharmacological research, 34(3-4), 1996, pp. 99-103
DOES TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) RELATE TO TISSUE POLYPEPTIDE ANTIGEN (TPA) IN EHRLICH ASCITES-CARCINOMA (EAC)-BEARING MICE
Authors: HALIM AB ELAHMADY O EISSA S BADARY OA AGHA A OEHR P
Citation: Ab. Halim et al., DOES TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) RELATE TO TISSUE POLYPEPTIDE ANTIGEN (TPA) IN EHRLICH ASCITES-CARCINOMA (EAC)-BEARING MICE, Journal of tumor marker oncology, 11(3), 1996, pp. 23-28
INTERFERON ENHANCEMENT OF TAMOXIFEN EFFICACY IN EHRLICH ASCITES-CARCINOMA - A FOLLOW-UP-STUDY OF TISSUE POLYPEPTIDE ANTIGEN
Authors: BADARY OA AGHA AM HALIM AB ELAHMADY O
Citation: Oa. Badary et al., INTERFERON ENHANCEMENT OF TAMOXIFEN EFFICACY IN EHRLICH ASCITES-CARCINOMA - A FOLLOW-UP-STUDY OF TISSUE POLYPEPTIDE ANTIGEN, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 225-232
Risultati: 1-10 |